IRIS
MARZIONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.638
EU - Europa 5.101
AS - Asia 4.240
SA - Sud America 1.116
Continente sconosciuto - Info sul continente non disponibili 475
AF - Africa 230
OC - Oceania 7
Totale 23.807
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.270
SG - Singapore 1.321
IT - Italia 975
VN - Vietnam 946
RU - Federazione Russa 874
BR - Brasile 862
CN - Cina 685
UA - Ucraina 677
IE - Irlanda 447
DE - Germania 427
SE - Svezia 403
HK - Hong Kong 369
FR - Francia 329
GB - Regno Unito 239
DK - Danimarca 224
FI - Finlandia 217
TR - Turchia 204
CA - Canada 159
BD - Bangladesh 143
KR - Corea 117
IN - India 115
AR - Argentina 80
MA - Marocco 60
CI - Costa d'Avorio 59
PL - Polonia 57
NL - Olanda 56
ES - Italia 53
MX - Messico 47
EC - Ecuador 46
IQ - Iraq 46
JP - Giappone 46
ID - Indonesia 44
ZA - Sudafrica 42
CR - Costa Rica 41
CO - Colombia 38
IL - Israele 31
PY - Paraguay 25
VE - Venezuela 25
BE - Belgio 24
PK - Pakistan 22
AT - Austria 21
UZ - Uzbekistan 20
NI - Nicaragua 19
PH - Filippine 19
HN - Honduras 18
CL - Cile 17
TT - Trinidad e Tobago 17
TN - Tunisia 16
GT - Guatemala 15
SV - El Salvador 14
LT - Lituania 13
SA - Arabia Saudita 13
JO - Giordania 12
TH - Thailandia 12
CW - ???statistics.table.value.countryCode.CW??? 11
SC - Seychelles 11
PE - Perù 10
PR - Porto Rico 10
RO - Romania 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
DZ - Algeria 9
GP - Guadalupe 9
EG - Egitto 8
JM - Giamaica 8
RS - Serbia 8
TW - Taiwan 7
EE - Estonia 6
ET - Etiopia 6
EU - Europa 6
KE - Kenya 6
LB - Libano 6
IR - Iran 5
MY - Malesia 5
AL - Albania 4
AO - Angola 4
BY - Bielorussia 4
CH - Svizzera 4
PS - Palestinian Territory 4
PT - Portogallo 4
AM - Armenia 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HU - Ungheria 3
KZ - Kazakistan 3
LV - Lettonia 3
MN - Mongolia 3
NP - Nepal 3
OM - Oman 3
SN - Senegal 3
BG - Bulgaria 2
BO - Bolivia 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
Totale 23.316
Salva come PNG Salva come JPEG
Città #
Ashburn 2.005
Chandler 765
Singapore 759
Jacksonville 699
Dallas 685
Fairfield 593
Council Bluffs 529
San Jose 511
Dublin 444
Des Moines 431
Boardman 399
Hong Kong 350
New York 327
Ho Chi Minh City 287
Wilmington 280
Woodbridge 279
Houston 271
The Dalles 236
Seattle 233
Hanoi 230
Los Angeles 230
Cambridge 207
Centro 202
Lauterbourg 170
Princeton 164
Lawrence 161
San Mateo 148
Moscow 129
Beijing 126
Ann Arbor 124
Santa Clara 89
San Diego 86
Hefei 83
Chicago 79
Buffalo 78
Munich 77
São Paulo 77
Milan 75
Orem 74
Phoenix 67
Helsinki 66
Washington 65
Abidjan 59
London 58
Montreal 53
Rome 52
Da Nang 51
Haiphong 46
Warsaw 42
Denver 41
Turku 41
Brooklyn 38
Turin 37
Guangzhou 36
Ancona 34
Rio de Janeiro 34
Shanghai 33
Nuremberg 31
Tokyo 31
Atlanta 30
San José 30
Chennai 26
Johannesburg 26
Toronto 26
San Francisco 24
Columbus 23
Wuhan 23
Baghdad 22
Salt Lake City 22
Hải Dương 19
Miano 19
Naples 19
Pune 19
Brussels 18
Frankfurt am Main 18
Guayaquil 18
Stockholm 18
Ankara 17
Irvington 17
Manchester 17
Norwalk 17
Poplar 17
Managua 16
Marche 16
Mexico City 16
Tashkent 16
Brasília 15
Boston 14
City of London 14
Elk Grove Village 14
Palermo 14
Porto Alegre 14
Tampa 14
Thái Nguyên 14
Wuxi 14
Salvador 13
Belo Horizonte 12
Bắc Ninh 12
Can Tho 12
Jiaxing 12
Totale 14.344
Salva come PNG Salva come JPEG
Nome #
EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma 340
Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis 230
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 214
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 209
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 203
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 195
Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota 188
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 182
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 181
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 181
Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes 179
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. 178
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. 178
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 177
Aging and the Biological Response to Liver Injury 177
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 175
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis 171
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 165
Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals 165
Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. 163
Bullous pemphigoid of Lever and celiac disease: a coincidental occurrence or an unusual association? 163
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 163
Descriptive epidemiology of cholangiocarcinoma in Italy. 160
Cholangiocarcinoma 2020: the next horizon in mechanisms and management 160
Leptin enhances cholangiocarcinoma cell growth. 158
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 157
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 157
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions 157
Clinical implications of novel aspects of biliary pathophysiology. 156
Current targets for Primary Sclerosing cholangitis 154
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma 154
Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology 154
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 152
Exendin-4, a Glucagon-Like Peptide 1 receptor agonist, protects cholangiocytes from apoptosis 152
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway 151
Administration of r-VEGF-A prevents hepatic artery ligation induced bile duct damage in bile duct ligated rats. 151
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 151
Functional and Structural Features of Cholangiocytes in Health and Disease 151
Bile acid depletion and repletion regulate cholangiocyte proliferation and secretion in bile duct ligated rats through a phosphatidylinositol 3-kinase-dependent pathway. 150
Cholangiocarcinoma development: the resurgence of bile acids 150
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 150
CAMP STIMULATES THE SECRETORY AND PROLIFERATIVE CAPACITY OF THE RAT BILIARY EPITHELIUM THROUGH CHANGES IN THE PKA/SRC/MEK/ERK1/2 PATHWAY 149
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 149
Hepatitis E in a region of Italy: An emerging autochthonous infection? 148
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 148
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis 146
Increased local dopamine secretion has growth promoting effects in cholangiocarcinoma. 145
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 143
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies 142
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 141
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells 141
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 141
Current and novel therapeutic opportunities for systemic therapy in biliary cancer 141
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic Acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts 140
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. 140
Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology 140
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis 140
Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms. 140
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 139
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 136
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 136
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models 136
The Impact of Radiofrequency Ablation on Survival Outcomes and Stent Patency in Patients with Unresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 135
Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. 135
Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment 135
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 134
Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis 134
Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy 134
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 132
Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice 132
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 131
Glucagon-like Peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis 130
Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 130
Selective Na+/H+ inhibition by cariporide reduces liver fibrosis in the rat 128
Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin 128
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 127
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 127
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 127
Involvement of autophagy in ageing and chronic cholestatic diseases 126
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach 126
Role of cholangiocytes in primary biliary cirrhosis 125
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 125
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 125
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. 124
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 124
Autocrine Regulation of Biliary Pathology by Activated Cholangiocytes. 123
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 123
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 123
Functional heterogeneity of the intrahepatic biliary tree 122
Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies 122
Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 121
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 121
Role of apoptosis in development of primary biliary cirrhosis 120
Risk Stratification in Primary Biliary Cholangitis 120
Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database 119
Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases 119
Development and functional characterization of extrahepatic cholangiocyte lines from normal rats 119
The management of cholestatic liver diseases: Current therapies and emerging new possibilities 118
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis 117
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 116
Totale 14.860
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022884 0 0 0 0 14 68 79 83 67 98 219 256
2022/20232.495 212 202 140 188 154 616 4 160 600 13 159 47
2023/20241.519 246 33 118 302 241 326 16 29 11 27 10 160
2024/20252.771 317 277 103 45 82 115 159 96 702 206 282 387
2025/20268.578 501 450 695 1.099 840 573 1.451 828 723 740 287 391
2026/20272.641 566 352 440 1.034 249 0 0 0 0 0 0 0
Totale 23.807